Zacks Research Has Pessimistic View of Ovintiv Q2 Earnings

Ovintiv Inc. (NYSE:OVV - Free Report) - Equities research analysts at Zacks Research cut their Q2 2025 earnings per share (EPS) estimates for Ovintiv in a research report issued to clients and investors on Tuesday, May 27th. Zacks Research analyst R. Department now forecasts that the company will post earnings per share of $1.01 for the quarter, down from their previous estimate of $1.14. The consensus estimate for Ovintiv's current full-year earnings is $5.59 per share. Zacks Research also issued estimates for Ovintiv's Q4 2025 earnings at $1.36 EPS and Q2 2026 earnings at $1.08 EPS.

A number of other equities research analysts also recently commented on OVV. BMO Capital Markets raised Ovintiv from a "market perform" rating to an "outperform" rating and lifted their target price for the stock from $55.00 to $57.00 in a report on Monday, March 24th. National Bankshares lifted their target price on Ovintiv from $51.00 to $56.00 and gave the stock an "outperform" rating in a report on Thursday, January 30th. Mizuho decreased their target price on Ovintiv from $60.00 to $58.00 and set an "outperform" rating for the company in a report on Tuesday, May 13th. Williams Trading set a $58.00 target price on Ovintiv in a report on Wednesday, March 5th. Finally, Wells Fargo & Company lifted their target price on Ovintiv from $45.00 to $46.00 and gave the stock an "equal weight" rating in a report on Tuesday, April 22nd. Two analysts have rated the stock with a hold rating, thirteen have given a buy rating and two have assigned a strong buy rating to the company. Based on data from MarketBeat, the stock has an average rating of "Buy" and an average target price of $55.65.

Ovintiv Stock Performance

Shares of Ovintiv stock traded down $0.73 on Thursday, reaching $35.80. 24,051,027 shares of the stock were exchanged, compared to its average volume of 3,344,411. The company has a quick ratio of 0.52, a current ratio of 0.52 and a debt-to-equity ratio of 0.46. Ovintiv has a twelve month low of $29.80 and a twelve month high of $51.72. The firm has a market capitalization of $9.30 billion, a price-to-earnings ratio of 4.75 and a beta of 1.14. The business has a 50 day moving average price of $35.99 and a two-hundred day moving average price of $40.25.

Ovintiv (NYSE:OVV - Get Free Report) last issued its quarterly earnings results on Tuesday, May 6th. The company reported $1.42 earnings per share for the quarter, topping the consensus estimate of $1.20 by $0.22. Ovintiv had a return on equity of 17.87% and a net margin of 20.15%. The business had revenue of $2.38 billion during the quarter, compared to the consensus estimate of $2.23 billion.

Ovintiv Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Monday, June 30th. Stockholders of record on Friday, June 13th will be given a $0.30 dividend. This represents a $1.20 dividend on an annualized basis and a dividend yield of 3.35%. The ex-dividend date is Friday, June 13th. Ovintiv's dividend payout ratio (DPR) is presently 51.06%.

Institutional Trading of Ovintiv

A number of institutional investors and hedge funds have recently made changes to their positions in OVV. Charles Schwab Investment Management Inc. increased its position in shares of Ovintiv by 383.8% in the first quarter. Charles Schwab Investment Management Inc. now owns 9,258,570 shares of the company's stock valued at $396,267,000 after buying an additional 7,344,796 shares in the last quarter. Arrowstreet Capital Limited Partnership increased its position in shares of Ovintiv by 1,732.9% in the fourth quarter. Arrowstreet Capital Limited Partnership now owns 3,387,923 shares of the company's stock valued at $137,134,000 after buying an additional 3,203,087 shares in the last quarter. Price T Rowe Associates Inc. MD increased its position in shares of Ovintiv by 1,577.4% in the fourth quarter. Price T Rowe Associates Inc. MD now owns 2,458,881 shares of the company's stock valued at $99,587,000 after buying an additional 2,312,292 shares in the last quarter. AQR Capital Management LLC increased its position in shares of Ovintiv by 69.7% in the first quarter. AQR Capital Management LLC now owns 5,572,732 shares of the company's stock valued at $238,513,000 after buying an additional 2,288,989 shares in the last quarter. Finally, Alyeska Investment Group L.P. increased its position in shares of Ovintiv by 243.6% in the fourth quarter. Alyeska Investment Group L.P. now owns 2,564,698 shares of the company's stock valued at $103,870,000 after buying an additional 1,818,337 shares in the last quarter. 83.81% of the stock is currently owned by hedge funds and other institutional investors.

About Ovintiv

Ovintiv Inc, together with its subsidiaries, explores, develops, produces, and markets natural gas, oil, and natural gas liquids in the United States and Canada. The company operates through USA Operations, Canadian Operations, and Market Optimization segments. Its principal assets include Permian in west Texas and Anadarko in west-central Oklahoma; and Montney in northeast British Columbia and northwest Alberta.